Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Natasha Mason and Zeus Tipado will be presenting at ICPR 2024 in Haarlem, Netherlands this June!
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team will organize a mini-symposium on psychedelics. We will welcome two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also have several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg). All students and staff with an interest in this topic are welcome to join us in the Maastrichtzaal in UNS40 between 13:30-15:30.
If you can’t make it, a live stream will be available at the link below!
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. Eef Theunissen
Cognition, Synthetic Cannabinoids, Drugs and Driving
I began my Ph.D. journey in 2001 at the Faculty of Psychology at the University of Maastricht. My research focused on investigating the sedating and stimulating effects of antihistamines, with a particular emphasis on their...
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Dr. Rudy Schreiber
CNS Drug Discovery, Research Domain Criteria
I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies
Henry Whitfeld, MSc
Psilocybin, Psychotherapy, Ideography
After being a psychological therapist with 20years experience in trauma work and mindfulness-informed approaches, I am now a researcher investigating how psychedelic experiences and psychotherapeutic protocols interact.
Prof. Arjan Blokland
Cognition, Learning & Memory, Acetylcholine
I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.
Dr. Samuli Kangaslampi
Most of my previous research has focused on psychological trauma, trauma-related disorders, trauma-focused psychotherapies, as well as autobiographical memory.
Prof. Jan Ramaekers
I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance.
Janine Kox, MSc
Stress Resilience, Psychedelics, Cognitive biases
My research focuses on the effects of stress, sleep deprivation, on cognitive biases, by using the transdiagnostic rDOC approach, and see whether psychedelics such as LSD, Psilocybin and even non-hallucinogenic psychedelics can reverse these effects.
Zeus Tipado, MSc
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
Psychedelic Research
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
divergent thinking, convergent thinking, Ayahuasca, creativity
→
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
→
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life
naturalistic, psychopathological, 5-MeO-DMT
→
Ritualistic use of ayahuasca enhances a shared functional connectome identity with others
Ayahuasca, Ritual, Functional Connectivity
→
Cannabis Research
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
→
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.